In silico experiment with an-antigen-toll like receptor-5 agonist fusion construct for immunogenic application to Helicobacter pylori

BACKGROUNDS: Helicobacter pylori colonize the gastric mucosa of half of the world's population. Although it is classified as a definitive type I carcinogen by World Health Organization, there is no effective vaccine against this bacterium. H. pylori evade the host immune response by avoiding to...

Descripción completa

Detalles Bibliográficos
Autores principales: Haghighi, Mohamad Ali, Mobarez, Ashraf Mohabati, Salmanian, Ali Hatef, Moazeni, Mohamad, Zali, Mohamad Reza, Sadeghi, Mehdi, Amani, Jafar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722629/
https://www.ncbi.nlm.nih.gov/pubmed/23901192
http://dx.doi.org/10.4103/0971-6866.112885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722629/
https://www.ncbi.nlm.nih.gov/pubmed/23901192
http://dx.doi.org/10.4103/0971-6866.112885

Ejemplares similares